# A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS)

> **NCT01822483** · PHASE4 · COMPLETED · sponsor: **Irmandade Santa Casa de Misericórdia de Porto Alegre** · enrollment: 100 (actual)

## Conditions studied

- Renal Transplantation

## Interventions

- **DRUG:** Mycophenolate sodium
- **DRUG:** Mycophenolate mofetil

## Key facts

- **NCT ID:** NCT01822483
- **Lead sponsor:** Irmandade Santa Casa de Misericórdia de Porto Alegre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2015-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01822483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01822483, "A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01822483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*